The company's fundamentals are relatively healthy. Its valuation is considered fairly valued,and institutional recognition is very high. Over the past 30 days, multiple analysts have rated the company as a Buy. Despite a very weak stock market performance, the company shows strong technicals. The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
UnitedHealth Group Incorporated is an American multinational for-profit organization that specializes in health insurance and healthcare services, located in Eden Prairie, Minnesota. Operating under the UnitedHealthcare brand for insurance products and the Optum brand for healthcare services, it is recognized as the world's seventh-largest company by revenue and the largest healthcare corporation by revenue. The company ranks 8th on the 2024 Fortune Global 500 list, with a market capitalization of $460.3 billion as of December 20, 2024. UnitedHealth Group has encountered numerous investigations, lawsuits, and penalties—including SEC enforcement related to stock option backdating, Medicare overbilling, unfair claims practices, denials of mental health treatments, and anticompetitive conduct—illuminating deep-rooted issues of fraud, patient harm, and corporate misconduct.
The company's current financial score is 5.14, which is lower than the Healthcare Services & Equipment industry's average of 7.15. Its financial status is stable, and its operating efficiency is low. Its latest quarterly revenue reached 109.58B, representing a year-over-year increase of 9.80%, while its net profit experienced a year-over-year increase of 546.56%.
The company’s current valuation score is 4.80, which is higher than the Healthcare Services & Equipment industry's average of 2.15. Its current P/E ratio is 13.10, which is 126.32% below the recent high of 29.64 and -67.35% above the recent low of 21.92.
The company’s current earnings forecast score is 7.43, which is lower than the Healthcare Services & Equipment industry's average of 7.66. The average price target for Unitedhealth Group Inc is 321.00, with a high of 677.00 and a low of 198.00.
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
The company’s current price momentum score is 9.31, which is higher than the Healthcare Services & Equipment industry's average of 7.47. Sideways: Currently, the stock price is trading between the resistance level at 335.32 and the support level at 253.52, making it suitable for range-bound swing trading.
The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.
This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.
Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.
The company’s current institutional recognition score is 10.00, which is higher than the Healthcare Services & Equipment industry's average of 7.19. The latest institutional shareholding proportion is 90.53%, representing a quarter-over-quarter decrease of 1.17%. The largest institutional shareholder is The Vanguard, holding a total of 90.50M shares, representing 9.99% of shares outstanding, with 8.52% increase in holdings.
The company's beta value is 0.44. This indicates that the stock tends to underperform the index during upward trending markets but experiences smaller declines during downward trending markets.
The Stock Score data is powered by TradingKey and updated daily. Rating data is sourced from LESG. Please use the data with caution for reference purposes only.
